Viral drug resistance and fitness.
Quiñones-Mateu
Miguel E
ME
HIV-1 Program, Diagnostic Hybrids, Athens, Ohio 45701, USA.
Moore-Dudley
Dawn M
DM
Jegede
Oyebisi
O
Weber
Jan
J
J Arts
Eric
E
D044966:Anti-Retroviral Agents / Q000494:pharmacology*; D024882:Drug Resistance, Viral / Q000502:physiology*; D023581:HIV Fusion Inhibitors / Q000494:pharmacology; D019428:HIV Integrase Inhibitors / Q000494:pharmacology; D017320:HIV Protease Inhibitors / Q000494:pharmacology; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology
D044966:Anti-Retroviral Agents; D023581:HIV Fusion Inhibitors; D019428:HIV Integrase Inhibitors; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors